lobbying_filings: 35862bda-74e9-4be6-a097-dc08c83c8faa
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | registrant_state | registrant_country | registrant_house_id | client_id | client_name | client_state | client_ppb_state | client_country | client_ppb_country | client_general_description | client_government_entity | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | affiliated_org_count |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35862bda-74e9-4be6-a097-dc08c83c8faa | Q2 | 401103321 | TODD STRATEGY GROUP | DC | US | 56475 | FERRING PHARMACEUTICALS INC. | NJ | NJ | US | US | Biopharmaceutical company. | 2025 | second_quarter | 2025-07-19T14:48:41-04:00 | 50000.0 | 0 | 0 | 0 | 0 |